Dx Dialogues: Chronic Obstructive Pulmonary Disease
- Dx Dialogues
- Dx Dialogues: Chronic Obstructive Pulmonary Disease
In this video, Dr. Michael Czarnecki, Pulmonary and Critical Care physician, explores key developments in the evolving treatment of COPD. He reviews historical approaches to care and highlights the impact of triple therapy in managing symptoms and exacerbations. Dr. Czarnecki also discusses emerging therapies, including monoclonal antibodies and biologics, emphasizing their potential to reduce inflammation, improve lung function, and lower the risk of exacerbations. He underscores the importance of staying current with advancements in COPD management to optimize patient outcomes.
Dx Dialogues: The historical approach to COPD treatment
Dx Dialogues: New treatment advances & future treatments for COPD
Dx Dialogues: The importance of staying up to date with COPD
Featured Content
Article
Breaking new ground: emerging therapies for COPD managementNovel approaches offer new hope for reducing exacerbations and improving lung function
Article
Beyond bronchodilation: how biologic therapies are redefining COPD managementTargeting inflammation offers a new pathway for improving patient outcomes
Article
From asthma to COPD: expanding the role of biologic therapiesMedications initially approved for other inflammatory diseases are now reshaping COPD management
Article
The future of COPD care: targeting inflammation for long-term disease controlAdvancements in biologics, PDE4 inhibitors, and regenerative medicine shape the next era of COPD treatment
